Journal of Antimicrobial Chemotherapy, Vol 41, 43-47, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
E Markopulos, W Graninger and A Georgopoulos
Clinical isolates of Enterococcus faecium, Enterococcus faecalis and
Staphylococcus epidermidis were studied for their ability to develop
resistance by two selection methods, one in broth and one on agar. The MICs
for enterococci after exposure to vancomycin ranged from 0.5 mg/L to 4
mg/L, and those after exposure to teicoplanin ranged from 0.25 mg/L to 1
mg/L. No significant increases occurred for E. faecalis, whilst two
isolates of E. faecium showed increases of up to eight-fold (from 0.125
mg/L to 1 mg/L). Vancomycin MICs ranged from 1 mg/L to 4 mg/L and
teicoplanin MICs reached 32 mg/L for S. epidermidis. Pulsed- field gel
electrophoresis analysis of SmaI-digested whole chromosomal DNA was
performed to compare the genomic DNA of glycopeptide-exposed and wild-type
strains. In-vitro exposure to vancomycin did not alter MICs significantly
except in one S. epidermidis isolate for which the MIC reached 4 mg/L,
whereas the teicoplanin-exposed cultures of S. epidermidis showed increases
of up to 64 times the original MIC. Comparable results were achieved with
the two selection methods.
ORIGINAL ARTICLES
In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis
Department of Infectious Diseases and Chemotherapy, University Clinic of Internal Medicine I, Vienna, Austria.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Buxbaum, C. Kratzer, W. Graninger, and A. Georgopoulos Antimicrobial and toxicological profile of the new biocide Akacid plus(R) J. Antimicrob. Chemother., July 1, 2006; 58(1): 193 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Kim, D. Xuan, R. Quintiliani, C. H. Nightingale, and D. P. Nicolau Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam J. Antimicrob. Chemother., August 1, 2001; 48(2): 259 - 267. [Abstract] [Full Text] [PDF] |
||||
